iRhythm Technologies receives another FDA 510(k) for AFib Monitoring System

iRhythm Technologies announced it has received another FDA 510(k) clearance for its ZEUS (Zio ECG Utilization Software) System that works with a wearable to monitor patients with atrial fibrillation, an irregular heart rhythm. Developed in partnership with Alphabet life science subsidiary Verily, the ZEUS System is a platform that works with the Zio Watch to detect AFib, characterize the amount of AFib a patient is experiencing and integrate with a clinician's workflow. iRhythm chief technology officer Mark Day told MobiHealthNews the latest clearance is for an algorithm that offers context on how much AFib the patient is experiencing over time.